Dolby Total Current Liabilities vs Total Liab Analysis
DLB Stock | USD 81.01 1.72 2.17% |
Dolby Laboratories financial indicator trend analysis is much more than just examining Dolby Laboratories latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Dolby Laboratories is a good investment. Please check the relationship between Dolby Laboratories Total Current Liabilities and its Total Liab accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Dolby Laboratories. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. For information on how to trade Dolby Stock refer to our How to Trade Dolby Stock guide.
Total Current Liabilities vs Total Liab
Total Current Liabilities vs Total Liab Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Dolby Laboratories Total Current Liabilities account and Total Liab. At this time, the significance of the direction appears to have almost identical trend.
The correlation between Dolby Laboratories' Total Current Liabilities and Total Liab is 0.98. Overlapping area represents the amount of variation of Total Current Liabilities that can explain the historical movement of Total Liab in the same time period over historical financial statements of Dolby Laboratories, assuming nothing else is changed. The correlation between historical values of Dolby Laboratories' Total Current Liabilities and Total Liab is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Current Liabilities of Dolby Laboratories are associated (or correlated) with its Total Liab. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Liab has no effect on the direction of Total Current Liabilities i.e., Dolby Laboratories' Total Current Liabilities and Total Liab go up and down completely randomly.
Correlation Coefficient | 0.98 |
Relationship Direction | Positive |
Relationship Strength | Very Strong |
Total Current Liabilities
Total Current Liabilities is an item on Dolby Laboratories balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Dolby Laboratories are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.Total Liab
The total amount of all liabilities that a company has, including both short-term and long-term liabilities.Most indicators from Dolby Laboratories' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Dolby Laboratories current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Dolby Laboratories. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. For information on how to trade Dolby Stock refer to our How to Trade Dolby Stock guide.At present, Dolby Laboratories' Issuance Of Capital Stock is projected to decrease significantly based on the last few years of reporting. The current year's Enterprise Value Over EBITDA is expected to grow to 26.65, whereas Selling General Administrative is forecasted to decline to about 186.3 M.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 1.1B | 892.2M | 1.0B | 771.3M | Total Revenue | 1.3B | 1.0B | 1.2B | 837.9M |
Dolby Laboratories fundamental ratios Correlations
Click cells to compare fundamentals
Dolby Laboratories Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Dolby Laboratories fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 2.9B | 3.1B | 2.7B | 3.0B | 3.4B | 2.0B | |
Total Stockholder Equity | 2.4B | 2.6B | 2.2B | 2.4B | 2.7B | 1.6B | |
Net Debt | (990.7M) | (1.2B) | (569.2M) | (694.7M) | (625.2M) | (656.5M) | |
Cash | 1.1B | 1.2B | 620.1M | 745.4M | 857.2M | 591.4M | |
Cash And Short Term Investments | 1.1B | 1.3B | 809.3M | 884.5M | 1.0B | 756.2M | |
Common Stock Shares Outstanding | 102.9M | 104.6M | 102.0M | 97.6M | 112.2M | 113.8M | |
Liabilities And Stockholders Equity | 2.9B | 3.1B | 2.7B | 3.0B | 3.4B | 2.0B | |
Total Current Assets | 1.5B | 1.8B | 1.3B | 1.5B | 1.7B | 1.0B | |
Other Current Liab | 223.2M | 264.1M | 231.5M | 356.2M | 409.6M | 430.1M | |
Total Current Liabilities | 267.1M | 315.7M | 277.5M | 422.2M | 485.6M | 509.8M | |
Other Liab | 146.5M | 129.0M | 123.3M | 148.3M | 170.6M | 93.7M | |
Property Plant And Equipment Net | 618.5M | 601.5M | 560.0M | 521.8M | 600.0M | 326.9M | |
Current Deferred Revenue | 15.4M | 18.5M | 18.6M | 31.5M | 36.2M | 20.5M | |
Retained Earnings | 2.4B | 2.6B | 2.3B | 2.4B | 2.8B | 1.6B | |
Accounts Payable | 12.6M | 17.8M | 14.2M | 20.9M | 18.8M | 24.1M | |
Non Current Assets Total | 1.4B | 1.3B | 1.4B | 1.5B | 1.7B | 997.2M | |
Non Currrent Assets Other | 91.2M | 61.3M | 55.1M | 94.7M | 108.9M | 114.3M | |
Other Assets | 210.1M | 217.3M | 238.7M | 296.5M | 341.0M | 358.1M | |
Net Receivables | 341.7M | 414.9M | 419.7M | 444.4M | 511.0M | 536.6M | |
Good Will | 489.4M | 340.7M | 365.1M | 408.4M | 469.7M | 281.3M | |
Non Current Liabilities Total | 211.8M | 185.7M | 161.0M | 185.4M | 213.2M | 109.4M | |
Inventory | 25.6M | 11.0M | 23.5M | 35.6M | 41.0M | 43.0M | |
Other Current Assets | 53.0M | 62.7M | 23.2M | 50.7M | 45.6M | 45.6M | |
Other Stockholder Equity | 406K | 100K | 94K | (37.0M) | (33.3M) | (31.6M) | |
Total Liab | 478.9M | 501.5M | 438.5M | 607.6M | 698.7M | 733.7M | |
Property Plant And Equipment Gross | 618.5M | 601.5M | 560.0M | 521.8M | 600.0M | 326.9M | |
Accumulated Other Comprehensive Income | (10.6M) | (10.0M) | (51.6M) | (37.0M) | (33.3M) | (31.6M) | |
Short Term Debt | 15.8M | 15.4M | 13.3M | 13.6M | 15.7M | 16.5M | |
Intangible Assets | 152.4M | 122.9M | 112.3M | 167.4M | 192.5M | 106.4M | |
Property Plant Equipment | 542.0M | 534.4M | 560.0M | 521.8M | 600.0M | 319.4M | |
Short Term Investments | 46.9M | 38.8M | 189.2M | 139.1M | 125.2M | 138.8M | |
Net Tangible Assets | 1.9B | 2.1B | 1.8B | 1.8B | 2.0B | 1.7B |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Dolby Laboratories offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Dolby Laboratories' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Dolby Laboratories Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Dolby Laboratories Stock:Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Dolby Laboratories. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. For information on how to trade Dolby Stock refer to our How to Trade Dolby Stock guide.You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Complementary Tools for Dolby Stock analysis
When running Dolby Laboratories' price analysis, check to measure Dolby Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dolby Laboratories is operating at the current time. Most of Dolby Laboratories' value examination focuses on studying past and present price action to predict the probability of Dolby Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dolby Laboratories' price. Additionally, you may evaluate how the addition of Dolby Laboratories to your portfolios can decrease your overall portfolio volatility.
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |
Is Dolby Laboratories' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Dolby Laboratories. If investors know Dolby will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Dolby Laboratories listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.031 | Dividend Share 1.17 | Earnings Share 1.94 | Revenue Per Share 13.272 | Quarterly Revenue Growth (0.03) |
The market value of Dolby Laboratories is measured differently than its book value, which is the value of Dolby that is recorded on the company's balance sheet. Investors also form their own opinion of Dolby Laboratories' value that differs from its market value or its book value, called intrinsic value, which is Dolby Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Dolby Laboratories' market value can be influenced by many factors that don't directly affect Dolby Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Dolby Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine if Dolby Laboratories is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Dolby Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.